What is the current valuation of the US Eye Health Supplements Market?

The market valuation was 508.2 USD Million in 2024. Read More

What is the projected market size for the US Eye Health Supplements Market by 2035?

The market is projected to reach 970.2 USD Million by 2035. Read More

What is the expected CAGR for the US Eye Health Supplements Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 6.05%. Read More

Which companies are considered key players in the US Eye Health Supplements Market?

Key players include Bausch + Lomb, Alcon, Johnson & Johnson, Nutrafol, and others. Read More

What segment had the highest valuation in the US Eye Health Supplements Market in 2024?

General Eye Health had the highest valuation at 177.84 USD Million in 2024. Read More

Which distribution channel is projected to perform best in the US Eye Health Supplements Market?

Pharmacies are projected to perform best, with a valuation of 152.46 USD Million in 2024. Read More

What formulation type is expected to see significant growth in the US Eye Health Supplements Market?

Tablets, valued at 120.0 USD Million in 2024, are expected to see significant growth. Read More

Which demographic is projected to contribute the most to the US Eye Health Supplements Market?

Adults, with a valuation of 152.1 USD Million in 2024, are projected to contribute the most. Read More

What ingredient type is anticipated to be a major focus in the US Eye Health Supplements Market?

Vitamins, valued at 101.64 USD Million in 2024, are anticipated to be a major focus. Read More

How does the market for Eye Fatigue Relief compare to other segments in 2024?

The Eye Fatigue Relief segment was valued at 76.56 USD Million in 2024, indicating a competitive position. Read More

US Eye Health Supplements Market

ID: MRFR/HC/17819-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Eye Health Supplements Market Research Report By Ingredient Type (Lutein and Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin, Others), By Form (Capsules/Tablets, Liquid, Gummies, Softgel, Powder), By Application (Age-related Macular Degeneration, Cataract, Glaucoma, Eye Fatigue, Corneal Support, Eyelid Conjunctivitis, Others) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Hypermarkets & Supermarkets, E-Commerce) - Growth & Industry Forecast 2025 To 2035

US Eye Health Supplements Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Vision Improvement
  2. 4.1.2 Eye Fatigue Relief
  3. 4.1.3 Macular Degeneration Prevention
  4. 4.1.4 Dry Eye Relief
  5. 4.1.5 General Eye Health
2. 4.2 Healthcare, BY Formulation (USD Million)
  1. 4.2.1 Capsules
  2. 4.2.2 Tablets
  3. 4.2.3 Powders
  4. 4.2.4 Liquids
  5. 4.2.5 Gummies
3. 4.3 Healthcare, BY Distribution Channel (USD Million)
  1. 4.3.1 Online Retail
  2. 4.3.2 Pharmacies
  3. 4.3.3 Health Food Stores
  4. 4.3.4 Supermarkets
  5. 4.3.5 Specialty Stores
4. 4.4 Healthcare, BY Target Demographic (USD Million)
  1. 4.4.1 Adults
  2. 4.4.2 Seniors
  3. 4.4.3 Children
  4. 4.4.4 Athletes
  5. 4.4.5 Professionals
5. 4.5 Healthcare, BY Ingredient Type (USD Million)
  1. 4.5.1 Vitamins
  2. 4.5.2 Minerals
  3. 4.5.3 Herbal Extracts
  4. 4.5.4 Antioxidants
  5. 4.5.5 Omega Fatty Acids
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Bausch + Lomb (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Alcon (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Nutrafol (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 EyePromise (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Visionary Health (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Ocuvite (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Nature's Way (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 GNC (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY FORMULATION
4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
5. 6.5 US MARKET ANALYSIS BY TARGET DEMOGRAPHIC
6. 6.6 US MARKET ANALYSIS BY INGREDIENT TYPE
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY FORMULATION, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY FORMULATION, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY TARGET DEMOGRAPHIC, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY TARGET DEMOGRAPHIC, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY INGREDIENT TYPE, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY INGREDIENT TYPE, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  2. 7.2.2 BY FORMULATION, 2026-2035 (USD Million)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
  4. 7.2.4 BY TARGET DEMOGRAPHIC, 2026-2035 (USD Million)
  5. 7.2.5 BY INGREDIENT TYPE, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

Vision Improvement
Eye Fatigue Relief
Macular Degeneration Prevention
Dry Eye Relief
General Eye Health

Healthcare By Formulation (USD Million, 2026-2035)

Capsules
Tablets
Powders
Liquids
Gummies

Healthcare By Distribution Channel (USD Million, 2026-2035)

Online Retail
Pharmacies
Health Food Stores
Supermarkets
Specialty Stores

Healthcare By Target Demographic (USD Million, 2026-2035)

Adults
Seniors
Children
Athletes
Professionals

Healthcare By Ingredient Type (USD Million, 2026-2035)

Vitamins
Minerals
Herbal Extracts
Antioxidants
Omega Fatty Acids

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”